Stagaki E[au] - Search Results

Year	Number of Results
2008	2
2009	2
2010	1
2011	1
2018	1
2019	2
2020	1
2021	0

1

Mycophenolate mofetil as an alternative treatment in sarcoidosis.

Papiris S, Stagaki E, Papadaki G, Kolilekas L, Korbila I, Apollonatou V, Kallieri M, Gialafos H, Chatziioannou S, Papaioannou AI, Manali ED. Papiris S, et al. Among authors: stagaki e. Pulm Pharmacol Ther. 2019 Oct;58:101840. doi: 10.1016/j.pupt.2019.101840. Epub 2019 Sep 10. Pulm Pharmacol Ther. 2019. PMID: 31518648

2

Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity.

Anthi A, Stagaki E, Rallidis L, Konstantonis D, Evangelopoulos ME, Voumvourakis K, Armaganidis A, Orfanos SE. Anthi A, et al. Among authors: stagaki e. ERJ Open Res. 2020 Mar 16;6(1):00328-2019. doi: 10.1183/23120541.00328-2019. eCollection 2020 Jan. ERJ Open Res. 2020. PMID: 32201683 Free PMC article.

3

Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE).

Arvanitaki A, Boutsikou M, Anthi A, Apostolopoulou S, Avgeropoulou A, Demerouti E, Farmakis D, Feloukidis C, Giannakoulas G, Karvounis H, Karyofyllis P, Mitrouska I, Mouratoglou S, Naka KK, Orfanos SE, Panagiotidou E, Pitsiou G, Rammos S, Stagaki E, Stanopoulos I, Thomaidi A, Triantafyllidi H, Tsangaris I, Tsiapras D, Voudris V, Manginas A; Hellenic Society for the Study of Pulmonary Hypertension (HSSPH). Arvanitaki A, et al. Among authors: stagaki e. Pulm Circ. 2019 Oct 14;9(3):2045894019877157. doi: 10.1177/2045894019877157. eCollection 2019 Jul-Sep. Pulm Circ. 2019. PMID: 31662847 Free PMC article.

4

Serum Admission 25-Hydroxyvitamin D Levels and Outcomes in Initially Non-Septic Critically Ill Patients.

Vassiliou AG, Jahaj E, Mastora Z, Stagaki E, Orfanos SE, Kotanidou A. Vassiliou AG, et al. Among authors: stagaki e. Shock. 2018 Nov;50(5):511-518. doi: 10.1097/SHK.0000000000001105. Shock. 2018. PMID: 29337839

5

How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis?

Mermigkis C, Stagaki E, Tryfon S, Schiza S, Amfilochiou A, Polychronopoulos V, Panagou P, Galanis N, Kallianos A, Mermigkis D, Kopanakis A, Varouchakis G, Kapsimalis F, Bouros D. Mermigkis C, et al. Among authors: stagaki e. Sleep Breath. 2010 Dec;14(4):387-90. doi: 10.1007/s11325-010-0336-5. Epub 2010 Mar 16. Sleep Breath. 2010. PMID: 20232261

6

Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters.

Papakosta D, Pitsiou G, Daniil Z, Dimadi M, Stagaki E, Rapti A, Antoniou K, Tzouvelekis A, Kontakiotis T, Tryfon S, Polychronopoulos V, Bouros D. Papakosta D, et al. Among authors: stagaki e. Lung. 2011 Oct;189(5):391-9. doi: 10.1007/s00408-011-9304-5. Epub 2011 Jun 11. Lung. 2011. PMID: 21660584

7

Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis.

Mermigkis C, Stagaki E, Amfilochiou A, Polychronopoulos V, Korkonikitas P, Mermigkis D, Bregou M, Kouris N, Bouros D. Mermigkis C, et al. Among authors: stagaki e. Med Princ Pract. 2009;18(1):10-5. doi: 10.1159/000163039. Epub 2008 Dec 4. Med Princ Pract. 2009. PMID: 19060484 Free article.

8

The treatment of lupus pernio: results of 116 treatment courses in 54 patients.

Stagaki E, Mountford WK, Lackland DT, Judson MA. Stagaki E, et al. Chest. 2009 Feb;135(2):468-476. doi: 10.1378/chest.08-1347. Epub 2008 Sep 23. Chest. 2009. PMID: 18812454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results